| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | Director | Common Stock | 33,140 | $3.19 M | $96.38 | May 23, 2023 | Direct |
| GERON CORP | Director | Common Stock | 0 | $0 | $3.75 | May 15, 2024 | Direct |
| Aeglea BioTherapeutics, Inc. | Director | Director Stock Option (right to buy) | 43,000 | Jun 7, 2022 | Direct | ||
| GERON CORP | Director | Stock Option (right to buy) | 0 | May 15, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GERN | GERON CORP | May 15, 2024 | 3 | -63,350 | 4 | May 17, 2024 | Director |
| GERN | GERON CORP | May 9, 2024 | 1 | 0 | 4 | May 10, 2024 | Director |
| GERN | GERON CORP | May 31, 2023 | 1 | 0 | 4 | Jun 2, 2023 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 23, 2023 | 1 | 0 | 4 | May 24, 2023 | Director |
| GERN | GERON CORP | May 11, 2023 | 3 | -66,500 | 4 | May 11, 2023 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Apr 3, 2023 | 3 | -248,880 | 4 | Apr 4, 2023 | Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Jun 7, 2022 | 1 | 0 | 4 | Jun 9, 2022 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 24, 2022 | 1 | 0 | 4 | May 26, 2022 | Director |
| GERN | GERON CORP | May 10, 2022 | 1 | 0 | 4 | May 11, 2022 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Apr 14, 2022 | 3 | -196,350 | 4 | Apr 18, 2022 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Jan 14, 2022 | 3 | -213,138 | 4 | Jan 19, 2022 | Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Jun 8, 2021 | 1 | 0 | 4 | Jun 9, 2021 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 25, 2021 | 1 | 0 | 4 | May 27, 2021 | Director |
| GERN | GERON CORP | May 11, 2021 | 1 | 0 | 4 | May 13, 2021 | Director |